Camson Bio Technologies Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2019. For the quarter, the company reported revenue from operations of INR 11.854 million compared to INR 12.898 million a year ago. Loss for the period was INR 75.440 million compared to INR 42.620 million a year ago. Basic and diluted loss per share was INR 2.51 compared to basic and diluted loss per share of INR 1.42 a year ago.